Cargando…

Allosteric activation of PI3Kα by oncogenic mutations

Detalles Bibliográficos
Autores principales:	Burke, John E., Perisic, Olga, Williams, Roger L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712563/ https://www.ncbi.nlm.nih.gov/pubmed/23563630

Ejemplares similares

Activating Mutations in TOR Are in Similar Structures As Oncogenic Mutations in PI3KCα
por: Sturgill, Thomas W., et al.
Publicado: (2009)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
por: Burke, John E., et al.
Publicado: (2011)

PI3Kβ downstream of GPCRs – crucial partners in oncogenesis
por: Dbouk, Hashem A., et al.
Publicado: (2012)

STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts
por: Buckbinder, Leonard, et al.
Publicado: (2023)

Structural insights into the activation of ataxia-telangiectasia mutated by oxidative stress
por: Howes, Anna C., et al.
Publicado: (2023)

Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
por: Harris, Noah J, et al.
Publicado: (2023)

Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
por: Harris, Noah J, et al.
Publicado: (2023)

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells
por: Yuen, Hiu-Fung, et al.
Publicado: (2012)

The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activity
por: Masson, Glenn R., et al.
Publicado: (2016)

Hyper-activated PI3K-δ in immunodeficiency
por: Heurtier, Lucie, et al.
Publicado: (2015)

Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS)
por: Burke, John E., et al.
Publicado: (2013)

Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
por: Buchanan, Christina M., et al.
Publicado: (2013)

Regulation of oncogenic PI3-kinase signaling by JARID1B
por: Facompre, Nicole D., et al.
Publicado: (2017)

The role of PI3Kγ in metabolism and macrophage activation
por: Solinas, Giovanni, et al.
Publicado: (2017)

Unravelling the effect of the E545K mutation on PI3Kα kinase
por: Galdadas, Ioannis, et al.
Publicado: (2020)

A PI3K-WIPI2 positive feedback loop allosterically activates LC3 lipidation in autophagy
por: Fracchiolla, Dorotea, et al.
Publicado: (2020)

A small molecule PI3Kα activator for cardioprotection and neuroregeneration
por: Gong, Grace Q, et al.
Publicado: (2023)

The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site
por: Gulsevin, Alican, et al.
Publicado: (2021)

Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth
por: Ying, Zhe, et al.
Publicado: (2018)

Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability
por: Vanhaesebroeck, Bart, et al.
Publicado: (2019)

Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
por: LaRochelle, Jonathan R., et al.
Publicado: (2018)

The mechanism of PI3Kα activation at the atomic level
por: Zhang, Mingzhen, et al.
Publicado: (2019)

PKCβ Phosphorylates PI3Kγ to Activate It and Release It from GPCR Control
por: Walser, Romy, et al.
Publicado: (2013)

Is PI3K a Villain in Cystic Fibrosis?
por: Natarajan, Viswanathan
Publicado: (2020)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

TGFβ activates PI3K-AKT signaling via TRAF6
por: Song, Jie, et al.
Publicado: (2017)

Single-Molecule Study Reveals How Receptor and Ras Synergistically Activate PI3Kα and PIP(3) Signaling
por: Buckles, Thomas C., et al.
Publicado: (2017)

PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication
por: Geletu, Mulu, et al.
Publicado: (2019)

Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities
por: Hubbard, Paul A., et al.
Publicado: (2014)

Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα
por: Borsari, Chiara, et al.
Publicado: (2022)

Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway
por: Qin, Zhen-Qi, et al.
Publicado: (2020)

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2019)

Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes
por: Pakharukova, Natalia, et al.
Publicado: (2021)

Modulation of PI3K signaling to improve CAR T cell function
por: Zheng, Wenting, et al.
Publicado: (2018)

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
por: Zhang, Cheng, et al.
Publicado: (2020)

PI3Kα Inhibitors That Inhibit Metastasis
por: Schmidt-Kittler, Oleg, et al.
Publicado: (2010)

The role of PI3Kα isoform in cardioprotection
por: Rossello, Xavier, et al.
Publicado: (2017)

Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kα, in comparison to established pan PI3K inhibitors
por: Rewcastle, Gordon W, et al.
Publicado: (2017)

Integrin αIIb-Mediated PI3K/Akt Activation in Platelets
por: Niu, Haixia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_50a34llutuvaqv83ouqit202pa